Search JIM Advanced Search

Journal of Integrative Medicine ›› 2015, Vol. 13 ›› Issue (5): 341-346.doi: 10.1016/S2095-4964(15)60200-X

• Short Report • Previous Articles    

Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions

Chen Linga,b, Yuan Wangc, Ying-lu Fengd, Ya-ni Zhangc, Jun Lic, Xin-rui Huc,e, Li-na Wangc, Mao-feng Zhonge, Xiao-feng Zhaic, Irene Zolotukhina, Arun Srivastavaa,b, Chang-quan Lingc,f   

  1. a Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, USA
    b Shands Cancer Center, University of Florida College of Medicine, Gainesville, Florida 32611, USA
    c Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China
    d Department of Traditional Chinese Medicine, 401 Hospital of the Chinese People’s Liberation Army, Qingdao 266071, Shandong Province, China
    e Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    f E-Institute of TCM Internal Medicine, Shanghai Municipal Education Commission, Shanghai 201203, China
  • Received:2015-08-07 Accepted:2015-08-17 Online:2015-09-10 Published:2015-09-15

Recombinant adeno-associated virus (rAAV) serotype 2, 3 and 8 vectors are the most promising liver-tropic AAV serotype vectors. Liver diseases are significant problems in China. However, to date, few studies on AAV neutralizing antibodies (Nabs) were working with the Chinese population or with the rAAV3 vectors. The present study aimed to determine the prevalence of Nabs in Chinese population against wild-type AAV2, AAV3 and AAV8 capsids as well as additional two AAV3 variants. In addition, we performed a preliminary analysis to investigate the potential influence of traditional Chinese medicine body constitutions on AAV Nabs. Our work demonstrated that the majority of healthy Chinese subjects were positive for AAV Nabs, with the order of AAV2 > AAV3 = AAVLK03 > AAV8. There was no difference between: 1) AAV3 and its variants; 2) male and female subjects; and 3) different age cohorts (≤ 35, 36-50, and ≥ 51 years old). People in the Qi-deficiency constitution had significantly increased AAV8 Nabs than people in the Gentleness constitution. Our studies may have impact on the future clinical design of AAV-based gene therapy in the Chinese population.

Key words: Medicine, Chinese traditional, Recombinant adeno-associated virus vector, Neutralizing antibodies, Body constitutions

[1] Mingozzi F, High KA . Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet, 2011,12(5):341-355
doi: 10.1038/nrg2988 pmid: 21499295
[2] Liu Y, Kim YJ, Ji M, Fang J, Siriwon N, Zhang LI, Wang P . Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides. Mol Ther Methods Clin Dev, 2014, 1: 12
doi: 10.1038/mtm.2013.12 pmid: 26015948
[3] Ponnazhagan S, Mukherjee P, Yoder MC, Wang XS, Zhou SZ, Kaplan J, Wadsworth S, Srivastava A . Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene, 1997,190(1):203-210
doi: 10.1016/S0378-1119(96)00576-8
[4] Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA . Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet, 1997,16(3):270-276
doi: 10.1038/ng0797-270
[5] Asokan A, Schaffer DV, Samulski RJ . The AAV vector toolkit: poised at the clinical crossroads. Mol Ther, 2012,20(4):699-708
doi: 10.1038/mt.2011.287 pmid: 22273577
[6] Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA . Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med, 2006,12(3):342-347
doi: 10.1038/nm1358
[7] Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE, Ragni MV, Manno CS, Sommer J, Jiang H, Pierce GF, Ertl HC, High KA . CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat Med, 2007,13(4):419-422
doi: 10.1038/nm1549 pmid: 17369837
[8] Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A, 2002,99(18):11854-11859
doi: 10.1073/pnas.182412299
[9] Nakai H, Fuess S, Storm TA, Muramatsu S, Nara Y, Kay MA . Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol, 2005,79(1):214-224
doi: 10.1128/JVI.79.1.214-224.2005
[10] Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O’Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CY, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Cunningham JM, Srivastava D, Basner-Tschakarjan E, Mingozzi F, High KA, Gray JT, Reiss UM, Nienhuis AW, Davidoff AM . Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med, 2011,365(25):2357-2365
doi: 10.1056/NEJMoa1108046 pmid: 3265081
[11] Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, Della Peruta M, Lheriteau E, Patel N, Raj D, Riddell A, Pie J, Rangarajan S, Bevan D, Recht M, Shen YM, Halka KG, Basner-Tschakarjan E, Mingozzi F, High KA, Allay J, Kay MA, Ng CY, Zhou J, Cancio M, Morton CL, Gray JT, Srivastava D, Nienhuis AW, Davidoff AM . Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med, 2014,371(21):1994-2004
doi: 10.1056/NEJMoa1407309 pmid: 4278802
[12] Blacklow NR, Hoggan MD, Rowe WP . Isolation of adenovirus-associated viruses from man. Proc Natl Acad Sci U S A, 1967,58(4):1410-1415
doi: 10.1073/pnas.58.4.1410 pmid: 4295829
[13] Zincarelli C, Soltys S, Rengo G, Rabinowitz JE . Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther, 2008,16(6):1073-1080
doi: 10.1038/mt.2008.76
[14] Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, Zhong L, Agbandje-McKenna M, Srivastava A . Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Hum Gene Ther, 2010,21(12):1741-1747
doi: 10.1089/hum.2010.075
[15] Cheng B, Ling C, Dai Y, Lu Y, Glushakova LG, Gee SW, McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, Siemann D, Liu C, Srivastava A . Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther, 2012,19(4):375-384
doi: 10.1038/gt.2011.105
[16] Ling C, Wang Y, Zhang Y, Ejjigani A, Yin Z, Lu Y, Wang L, Wang M, Li J, Hu Z, Aslanidi GV, Zhong L, Gao G, Srivastava A . Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Hum Gene Ther, 2014,25(12):1023-1034
doi: 10.1089/hum.2014.099
[17] Lisowski L, Dane AP, Chu K, Zhang Y, Cunningham SC, Wilson EM, Nygaard S, Grompe M, Alexander IE, Kay MA . Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature, 2014,506(7488):382-386
doi: 10.1038/nature12875 pmid: 24390344
[18] Masat E, Pavani G, Mingozzi F . Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions. Discov Med, 2013,15(85):379-389
doi: 10.1590/1414-431X20131662 pmid: 23819952
[19] Calcedo R, Wilson JM . Humoral immune response to AAV. Front Immunol, 2013,4: 341
[20] Liu Q, Huang W, Zhao C, Zhang L, Meng S, Gao D, Wang Y . The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: implications for gene therapy and vaccines using AAV1 vector. J Med Virol, 2013,85(9):1550-1556
doi: 10.1002/jmv.v85.9
[21] Liu Q, Huang W, Zhang H, Wang Y, Zhao J, Song A, Xie H, Zhao C, Gao D . Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors. Gene Ther, 2014,21(8):732-738
doi: 10.1038/gt.2014.47
[22] van der Marel S, Comijn EM, Verspaget HW, van Deventer S, van den Brink GR, Petry H, Hommes DW, Ferreira V . Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapy. Inflamm Bowel Dis, 2011,17(12):2436-2442
doi: 10.1002/ibd.21673
[23] Parks WP, Boucher DW, Melnick JL, Taber LH, Yow MD . Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun, 1970,2(6):716-722
pmid: 16557905
[24] Mayor HD, Drake S, Stahmann J, Mumford DM . Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol, 1976,126(1):100-104
doi: 10.1016/0002-9378(76)90472-5
[25] Calcedo R, Vandenberghe LH, Gao G, Lin J, Wilson JM . Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis, 2009,199(3):381-390
doi: 10.1086/595830 pmid: 19133809
[26] Qu Y, Nie X, Yang Z, Yin H, Pang Y, Dong P, Zhan S . The prevalence of hemophilia in mainland China: a systematic review and meta-analysis. Southeast Asian J Trop Med Public Health, 2014,45(2):455-466
doi: 10.1016/j.socscimed.2013.11.018 pmid: 24968688
[27] Zhao CQ, Zhou Y, Ping J, Xu LM . Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med, 2014,12(5):401-408
doi: 10.1016/S2095-4964(14)60039-X
[28] Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C . Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J Integr Med, 2014,12(1):20-34
doi: 10.1016/S2095-4964(14)60003-0
[29] Wang Q, Zhu YB . Epidemiological investigation of constitutional types of Chinese medicine in general population: Base on 21,948 epidemiological investigation data of nine provinces in China. Zhonghua Zhong Yi Yao Za Zhi, 2009,24(1):7-12
[30] Meliani A, Leborgne C, Triffault S, Jeanson-Leh L, Veron P, Mingozzi F . Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter system. Hum Gene Ther Methods, 2015,26(2):45-53
doi: 10.1089/hgtb.2015.037
[31] Wang M, Crosby A, Hastie E, Samulski JJ, McPhee S, Joshua G, Samulski RJ, Li C . Prediction of adeno-associated virus neutralizing antibody activity for clinical application. Gene Ther. 2015 Jun 30. doi: 10.1038/gt.2015.69.[Epub ahead of print].
doi: 10.1038/gt.2015.69 pmid: 26125606
[32] Mimuro J, Mizukami H, Shima M, Matsushita T, Taki M, Muto S, Higasa S, Sakai M, Ohmori T, Madoiwa S, Ozawa K, Sakata Y . The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals. J Med Virol, 2014,86(11):1990-1997
doi: 10.1002/jmv.v86.11
[33] Yao SL, Zhang ZZ, Yang XS, Xu X, Cao J, Xie GY, Zhang Q . Analysis of composite traditional Chinese medicine constitution: an investigation of 974 volunteers. J Chin Integr Med, 2012,10(5):508-515
doi: 10.3736/jcim20120505
[34] Zhu YB, Wang Q, Wu CY, Pang GM, Zhao JX, Shen SL, Xia ZY, Yan X . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. J Chin Integr Med, 2010,8(11):1023-1028
doi: 10.3736/jcim201011
[35] Zhu YB, Wang Q, Chen KF, Wu YE, Hong WL, Liu L . Stratified analysis of the relationship between traditional Chinese medicine constitutional types and health status in the general population based on data of 8 448 cases. J Chin Integr Med, 2011,9(4):382-389
doi: 10.3736/jcim201104
[1] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[2] Jonathan M. Fields. Dangers of scientific bias against herbal drugs for coronavirus disease 2019. Journal of Integrative Medicine, 2020, 18(6): 459-461.
[3] Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384.
[4] Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). Journal of Integrative Medicine, 2020, 18(3): 203-213.
[5] Wen-jie Xu, Ling-tai Wang, Zhi-ping Zhao, Li-ming Zhu, Liang-hua Zu, Qi Zhang, Dan-bo Dou. Prospects of a comprehensive evaluation system for traditional Chinese medicine services. Journal of Integrative Medicine, 2017, 15(6): 426-432.
[6] Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. Journal of Integrative Medicine, 2017, 15(6): 469-475.
[7] Xiao Ye, Hong-xia Zhang. A history of standardization in the English translation of traditional Chinese medicine terminology. Journal of Integrative Medicine, 2017, 15(5): 344-350.
[8] Wan-fu Lin, Jian-ying Lu, Bin-bin Cheng, Chang-quan Ling. Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment. Journal of Integrative Medicine, 2017, 15(4): 282-287.
[9] Byung Hyuk Han, Yun Jung Lee, Jung Joo Yoon, Eun Sik Choi, Seung Namgung, Xian Jun Jin, Da Hye Jeong, Dae Gill Kang, Ho Sub Lee. Hwangryunhaedoktang exerts anti-inflammation on LPS-induced NO production by suppressing MAPK and NF-κB activation in RAW264.7 macrophages. Journal of Integrative Medicine, 2017, 15(4): 326-336.
[10] Chen Fu, Nevin Lianwen Zhang, Bao-xin Chen, Zhou Rong Chen, Xiang Lan Jin, Rong-juan Guo, Zhi-gang Chen, Yun-ling Zhang. Identification and classification of traditional Chinese medicine syndrome types among senior patients with vascular mild cognitive impairment using latent tree analysis. Journal of Integrative Medicine, 2017, 15(3): 186-200.
[11] Nevin Lianwen Zhang, Chen Fu, Teng Fei Liu, Bao-xin Chen, Kin Man Poon, Pei Xian Chen, Yunling Zhang. A data-driven method for syndrome type identification and classification in traditional Chinese medicine. Journal of Integrative Medicine, 2017, 15(2): 110-123.
[12] Jin Yu, Chao-qin Yu, Qi Cao, Li Wang, Wen-jun Wang, Li-rong Zhou, Jing Li, Qiao-hong Qian. Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft). Journal of Integrative Medicine, 2017, 15(2): 102-109.
[13] Qian-wen Ma, Yong Tan. Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: A meta-analysis. Journal of Integrative Medicine, 2017, 15(2): 95-101.
[14] Wen-jian Wang, Teng Zhang. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine. Journal of Integrative Medicine, 2017, 15(1): 1-7.
[15] Xiao Ye, Min-hua Dong. A review on different English versions of an ancient classic of Chinese medicine: Huang Di Nei Jing. Journal of Integrative Medicine, 2017, 15(1): 11-18.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228